Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: J Psychosom Res. 2023 Sep 29;175:111510. doi: 10.1016/j.jpsychores.2023.111510

Table 3.

Outcomes: cumulative incidence percent and incidence rate, by PCL-5 severity (n=23,161)

Outcome Mild PTSD
(n=3959)		 Moderate PTSD
(n=15612)		 Severe PTSD
(n=3590)		 p-value
Starting insulin
#events (%) 450 (11.4) 1705 (10.9) 482 (13.4) <.001
Incidence rate per 1,000PY 23.8/1000PY 22.6/1000PY 27.3/1000PY .002
Poor glycemic control
#events (%) 1630 (41.2) 6590 (42.2) 1582 (44.1) .035
Incidence rate per 1,000PY 122.5/1000PY 125.5/1000PY 128.8/1000PY .364
Any microvascular complication
#events (%) 1690 (42.7) 6628 (42.5) 1571 (43.8) .362
Incidence rate per 1,000PY 116.7/1000PY 114.9/1000PY 116.0/1000PY .827
Mortality
#events (%) 329 (8.3) 1083 (6.9) 194 (5.4) <.001
Incidence rate per 1,000PY 15.7/1000PY 13.0/1000PY 9.9/1000PY <.001